{
    "text_blocks": {
        "data": {
            "block_count": 2,
            "table_index": 0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "0",
                    "1": "0",
                    "2": "0"
                },
                "decision": "0"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-01-21_09-33-00"
    },
    "table_comments": {
        "data": "CONSOLIDATED BALANCE SHEETS\t(In millions, except shares in thousands and per share data in dollars)\tJune 30, 2021\tDecember 31, 2020\t(Unaudited)\t",
        "timestamp": "2025-03-11_12-18-08"
    },
    "units": {
        "data": {
            "sum_units": 1000000,
            "sum_divider": 1.0
        },
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "votes": {
                    "0": "1000000",
                    "1": "1000000"
                },
                "decision": "1000000"
            },
            "gpt-4o-2024-08-06": {
                "votes": null,
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-18-11"
    },
    "post_table_text": {
        "data": "\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t1",
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "'\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t1'"
                },
                "decision": "'\tThe accompanying notes to the consolidated financial statements are an integral part of these statements.\t1'"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-11_12-18-13"
    },
    "table_body": {
        "data": "ASSETS\tCurrent assets:\tCash and cash equivalents\t$\t11,018\t$\t10,800\tPremium and trade receivables\t11,202\t9,696\tShort-term investments\t1,566\t1,580\tOther current assets\t1,678\t1,317\tTotal current assets\t25,464\t23,393\tLong-term investments\t13,472\t12,853\tRestricted deposits\t1,112\t1,060\tProperty, software and equipment, net\t2,912\t2,774\tGoodwill\t18,805\t18,652\tIntangible assets, net\t8,069\t8,388\tOther long-term assets\t1,705\t1,599\tTotal assets\t$\t71,539\t$\t68,719\tLIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS  EQUITY\tCurrent liabilities:\tMedical claims liability\t$\t12,763\t$\t12,438\tAccounts payable and accrued expenses\t8,053\t7,069\tReturn of premium payable\t2,127\t1,458\tUnearned revenue\t446\t523\tCurrent portion of long-term debt\t253\t97\tTotal current liabilities\t23,642\t21,585\tLong-term debt\t16,536\t16,682\tDeferred tax liability\t1,438\t1,534\tOther long-term liabilities\t3,795\t2,956\tTotal liabilities\t45,411\t42,757\tCommitments and contingencies\tRedeemable noncontrolling interests\t83\t77\tStockholders  equity:\tPreferred stock, $\t0.001\tpar value; authorized\t10,000\tshares;\tno\tshares issued or outstanding at June 30, 2021 and December 31, 2020\t \t \tCommon stock, $\t0.001\tpar value; authorized\t800,000\tshares;\t599,988\tissued and\t583,002\toutstanding at June 30, 2021, and\t598,249\tissued and\t581,479\toutstanding at December 31, 2020\t1\t1\tAdditional paid-in capital\t19,545\t19,459\tAccumulated other comprehensive earnings\t239\t337\tRetained earnings\t6,956\t6,792\tTreasury stock, at cost (\t16,986\tand\t16,770\tshares, respectively)\t(\t830\t)\t(\t816\t)\tTotal Centene stockholders  equity\t25,911\t25,773\tNonredeemable noncontrolling interest\t134\t112\tTotal stockholders  equity\t26,045\t25,885\tTotal liabilities, redeemable noncontrolling interests and stockholders  equity\t$\t71,539\t$\t68,719",
        "timestamp": "2025-03-11_12-18-13"
    },
    "table_json_created": {
        "data": true,
        "model": {
            "gpt-4o-mini-2024-07-18": {
                "trials": {
                    "0": "{\"ASSETS\": {\"Current assets\": {\"Cash and cash equivalents\": [11018, 10800], \"Premium and trade receivables\": [11202, 9696], \"Short-term investments\": [1566, 1580], \"Other current assets\": [1678, 1317], \"Total current assets\": [25464, 23393]}, \"Long-term investments\": [13472, 12853], \"Restricted deposits\": [1112, 1060], \"Property, software and equipment, net\": [2912, 2774], \"Goodwill\": [18805, 18652], \"Intangible assets, net\": [8069, 8388], \"Other long-term assets\": [1705, 1599], \"Total assets\": [71539, 68719]}, \"LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS EQUITY\": {\"Current liabilities\": {\"Medical claims liability\": [12763, 12438], \"Accounts payable and accrued expenses\": [8053, 7069], \"Return of premium payable\": [2127, 1458], \"Unearned revenue\": [446, 523], \"Current portion of long-term debt\": [253, 97], \"Total current liabilities\": [23642, 21585]}, \"Long-term debt\": [16536, 16682], \"Deferred tax liability\": [1438, 1534], \"Other long-term liabilities\": [3795, 2956], \"Total liabilities\": [45411, 42757], \"Commitments and contingencies\": null, \"Redeemable noncontrolling interests\": [83, 77], \"Stockholders equity\": {\"Preferred stock, $ 0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2021 and December 31, 2020\": [0, 0], \"Common stock, $ 0.001 par value; authorized 800,000 shares; 599,988 issued and 583,002 outstanding at June 30, 2021, and 598,249 issued and 581,479 outstanding at December 31, 2020\": [1, 1], \"Additional paid-in capital\": [19545, 19459], \"Accumulated other comprehensive earnings\": [239, 337], \"Retained earnings\": [6956, 6792], \"Treasury stock, at cost ( 16,986 and 16,770 shares, respectively)\": [-830, -816], \"Total Centene stockholders equity\": [25911, 25773], \"Nonredeemable noncontrolling interest\": [134, 112], \"Total stockholders equity\": [26045, 25885]}, \"Total liabilities, redeemable noncontrolling interests and stockholders equity\": [71539, 68719]}}"
                },
                "decision": "{\"ASSETS\": {\"Current assets\": {\"Cash and cash equivalents\": [11018, 10800], \"Premium and trade receivables\": [11202, 9696], \"Short-term investments\": [1566, 1580], \"Other current assets\": [1678, 1317], \"Total current assets\": [25464, 23393]}, \"Long-term investments\": [13472, 12853], \"Restricted deposits\": [1112, 1060], \"Property, software and equipment, net\": [2912, 2774], \"Goodwill\": [18805, 18652], \"Intangible assets, net\": [8069, 8388], \"Other long-term assets\": [1705, 1599], \"Total assets\": [71539, 68719]}, \"LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS EQUITY\": {\"Current liabilities\": {\"Medical claims liability\": [12763, 12438], \"Accounts payable and accrued expenses\": [8053, 7069], \"Return of premium payable\": [2127, 1458], \"Unearned revenue\": [446, 523], \"Current portion of long-term debt\": [253, 97], \"Total current liabilities\": [23642, 21585]}, \"Long-term debt\": [16536, 16682], \"Deferred tax liability\": [1438, 1534], \"Other long-term liabilities\": [3795, 2956], \"Total liabilities\": [45411, 42757], \"Commitments and contingencies\": null, \"Redeemable noncontrolling interests\": [83, 77], \"Stockholders equity\": {\"Preferred stock, $ 0.001 par value; authorized 10,000 shares; no shares issued or outstanding at June 30, 2021 and December 31, 2020\": [0, 0], \"Common stock, $ 0.001 par value; authorized 800,000 shares; 599,988 issued and 583,002 outstanding at June 30, 2021, and 598,249 issued and 581,479 outstanding at December 31, 2020\": [1, 1], \"Additional paid-in capital\": [19545, 19459], \"Accumulated other comprehensive earnings\": [239, 337], \"Retained earnings\": [6956, 6792], \"Treasury stock, at cost ( 16,986 and 16,770 shares, respectively)\": [-830, -816], \"Total Centene stockholders equity\": [25911, 25773], \"Nonredeemable noncontrolling interest\": [134, 112], \"Total stockholders equity\": [26045, 25885]}, \"Total liabilities, redeemable noncontrolling interests and stockholders equity\": [71539, 68719]}}"
            },
            "gpt-4o-2024-08-06": {
                "trials": {},
                "decision": null
            }
        },
        "timestamp": "2025-03-12_11-23-34"
    },
    "problems": {
        "data": [],
        "timestamp": "2025-03-12_11-23-34"
    }
}